← Back to Clinical Trials
Recruiting NCT06335563

NCT06335563 Augmented Reality Navigation Versus Traditional CT Guidance for Preoperative Localization of Pulmonary Nodules

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06335563
Status Recruiting
Phase
Sponsor Shanghai Pulmonary Hospital, Shanghai, China
Condition Pulmonary Nodule
Study Type INTERVENTIONAL
Enrollment 166 participants
Start Date 2024-03-14
Primary Completion 2024-12-01

Trial Parameters

Condition Pulmonary Nodule
Sponsor Shanghai Pulmonary Hospital, Shanghai, China
Study Type INTERVENTIONAL
Phase N/A
Enrollment 166
Sex ALL
Min Age 18 Years
Max Age 80 Years
Start Date 2024-03-14
Completion 2024-12-01
Interventions
AR glasses-assisted pulmonary nodule puncture localizationCT-guided pulmonary nodule puncture localization

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study aims to conduct a large-sample randomized controlled clinical trial, using traditional CT-guided thoracic puncture localization as a comparison, to explore the accuracy, safety and clinical advantages of Intelligent AR glasses in assisting preoperative localizing of small pulmonary nodules.

Eligibility Criteria

Inclusion Criteria: 1. Age 18-80, no gender limit; 2. Chest CT shows that the nodule involves the outer third of the lung and can be removed by wedge resection; 3. Chest CT (lung window mode), the maximum diameter of the nodule is ≤2 cm; 4. Physical condition score ECOG 0-2 points; 5. If you plan to undergo percutaneous puncture and localization of small pulmonary nodules, the puncture needle path will be determined by the attending physician; 6. Patients voluntarily participate and sign informed consent. Exclusion Criteria: 1. The lesion is located in front of the scapula, and the needle path is blocked; 2. The distance between the center of the lesion and the top of the diaphragm is \< 3 cm; 3. The lesion is adjacent to the hilus or large blood vessels; 4. Pleural adhesions caused by a history of thoracotomy or pleural infection; 5. The patient voluntarily withdraws midway.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology